Searched for
DYNAGLIPT
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Usually, official talks are mere formalities – meetings to ink things that have already been agreed upon. The one scheduled between the US ...
- Time to increase the risk quotient? Maybe, but selectively: 5 large-caps from different sectors with upside potential of up to 28%With Israel refusing to play ball and Iran maintaining its vice-like hold on the Strait of Hormuz, the ceasefire declared by US President T...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%The market is again abuzz with the possibility of peace in the Gulf. This has, however, happened in the past. There is, thus, no point in g...
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
- Manage volatility with diversification and selection: 8 large-cap stocks from different sectors with upside potential of up to 38%Normally, one-day moves of the indices should never be taken as a sign of what is in store for the market. However, there are times when ev...
- As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...
- Stay with select few with tailwinds of either restructuring or demand: 5 large-cap stocks from different sectors with an upside potential of 35%When it comes to large-caps, we think of Reliance, TCS, L&T or Infosys. The fact, however, is that these are not large-caps – they are mega...
- Corrections are opportunities, if you enter the right sector and stocks: 5 stocks from pharma sector with an upside potential of up to 32%At a time when the Nifty and Sensex are trading with cuts in excess of 1%, talking of buying stocks may not appear quite right. But correct...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Simple moat is good enough reason : 5 large cap stocks from different sector with right ratio matrix and upside potential of upto 38%There are many textbook definitions of the word “ moat”. But what it means in simple terms is that there has to be something in a business ...
- Volatility in market is different from volatile business: 5 large cap stocks with upside potential ranging from just 2% upto 46%There cannot be any doubt about volatility on the street, both as reflected by advance decline ratio or the kind of movement we see in nift...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- Drugmakers launch cut-price versions of type 2 diabetes medicineDozens of Indian drugmakers have launched cut-price versions of teneligliptin, a new generation medicine for type 2 diabetes patients.
- Mankind Pharma to invest Rs 200 crore to open 2 plants by mid-2016Mankind Pharma will invest Rs 200 crore to open two manufacturing plants in the country by the middle of 2016 as part of its expansion plan...
- Mankind pharma joins the anti-diabetic drug warIndia's anti-diabetic market is one of the fastest growing therapy segments, with a growth exceeding 25% at Rs 7638 crore, according to the...
- Mankind Pharma launches diabetes drug 'Dynaglipt'Mankind Pharma has launched an anti-diabetic product 'Dynaglipt' targeting the middle class and rural diabetic patients.
Load More
